New hope for Tough-to-Treat liver cancer
Disease control
Recruiting now
This study is testing whether combining two drugs, pemigatinib and durvalumab, can help control a specific type of advanced bile duct cancer that has a particular genetic change (FGFR-2). It is for adults whose cancer has worsened after initial treatment. The main goal is to see …
Phase: PHASE2 • Sponsor: Mehmet Akce • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC